Guru Ownership Trend
Guru Analysis for ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.32 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.88 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Steven Cohen reduced exposure by 32.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for ADC Therapeutics SA (ADCT)
Major holders include Steven Cohen ($12.68 M), Renaissance Technologies (RenTech) ($1.12 M), Cliff Asness ($891,141). According to the latest reported data, 3 tracked investment managers collectively hold approximately 3.92 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.88 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ADCT. The total reported sell value was $6.12 M.
Yes, 1 managers opened new positions in ADCT, and 1 increased their existing holdings. The total reported buy value was $1.24 M.